癌症患者PET/CT中小肠局灶性FDG摄取的发生率与病因
这项回顾性研究分析了147,516例癌症分期PET/CT检查,发现小肠局灶性FDG摄取罕见,发生率为0.1%(88/147,516)。其中60.2%(53/88)为转移性,最常见来自淋巴瘤(32.1%)和黑色素瘤(30.2%)。转移性病灶与远处其他转移灶、更高SUVmax及CT对应病变相关(P<0.01)。
要点
- 癌症分期PET/CT中小肠局灶性FDG摄取发生率仅0.1%。
- 小肠局灶性高代谢多数为转移,以淋巴瘤和黑色素瘤为主。
- 远处转移、高SUVmax及CT对应病变提示转移性。
核心结论
- 癌症患者PET/CT中小肠局灶性FDG摄取罕见,但多数为转移性,尤其见于淋巴瘤和黑色素瘤。
研究设计与样本
- 回顾性分析连续因癌症分期行FDG PET/CT且伴发小肠局灶性放射性示踪剂摄取的检查,排除已知小肠病变或参考标准不足者,以复合参考标准(组织病理学、临床和影像随访)确定病因。
主要发现
- 在147,516例PET/CT检查中,小肠局灶性FDG摄取发生率为0.1%(88/147,516)。
- 88例中60.2%(53/88)为转移性,最常见来自淋巴瘤32.1%(17/53)和黑色素瘤30.2%(16/53)。
- 转移性病灶在回肠分布47.2%(25/53)、空肠分布39.6%(21/53)。
- 转移性小肠局灶性FDG摄取与存在其他远处转移灶、更高SUVmax及CT对应病变相关(P<0.01)。
关键数值与推荐
- 转移性与良性小肠局灶性FDG摄取的鉴别参考因素包括是否存在其他远处转移、SUVmax水平及CT对应病变(P<0.01)。
临床怎么用
- 癌症分期PET/CT发现小肠局灶性FDG摄取时,应结合是否存在远处转移、SUVmax及CT对应病变综合判断转移可能性。
局限性
- 本研究为回顾性设计,排除了已知小肠病变或参考标准不足的病例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE OF THE REPORT: To determine the prevalence, etiology, and clinical significance of incidental focal small bowel FDG uptake in patients undergoing PET/CT for staging of non-small bowel cancers. MATERIAL AND METHODS: Retrospective review of consecutive FDG PET/CT examinations obtained for cancer staging with incidental focal small bowel radiotracer uptake was performed. Exclusion criteria included known small bowel pathology or insufficient reference standard. Imaging findings assessed included lesion location, number, CT correlate, SUV max , and presence of metastases outside the bowel. Clinical data included age, sex, cancer clinical setting, origin, and stage. Focal small bowel FDG uptake etiology (benign vs. metastatic) was determined by composite reference standard (histopathology, clinical, and imaging follow-up). Statistical analyses included Wilcoxon rank-sum test, Pearson's χ 2 test, Fisher exact test, and ROC curve analyses. RESULTS: In a review of 147,516 PET/CT examinations, incidental focal small bowel FDG uptake was rare, with a prevalence of 0.1% (88/147,516). Most cases were metastatic, 60.2% (53/88), most commonly spread from lymphoma [32.1% (17/53)] and melanoma [30.2% (16/53)]. Metastatic lesions were evenly distributed throughout the ileum [47.2% (25/53)] and jejunum [39.6% (21/53)]. Metastatic focal small bowel FDG uptake was associated with presence of other sites of distant metastases, higher SUV max , and presence of a CT correlate ( P <0.01). CONCLUSIONS: Incidental focal small bowel FDG uptake is rare. Most small bowel hypermetabolic foci are metastatic and are predominantly encountered with melanoma and lymphoma. Multiple imaging and clinical factors helped differentiate between benign and metastatic focal small bowel FDG uptake.
引用
- Charbel C, Woo S, Becker AS, et al. Focal Small Bowel FDG Uptake in Cancer Patients Undergoing PET/CT: Prevalence and Etiology. Clin Nucl Med. 2026. PMID: 42148841. doi:10.1097/RLU.0000000000006480
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。